Brain Cancer Health Center
Pituitary Tumors Treatment - Changes to This Summary (09 / 16 / 2008)
The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.
PURPOSE OF THIS PDQ SUMMARY
Editorial changes were made to this section.
WebMD Public Information from the National Cancer Institute
This information is produced and provided by the National Cancer Institute (NCI). The information in this topic may have changed since it was written. For the most current information, contact the National Cancer Institute via the Internet web site at http://cancer.gov or call 1-800-4-CANCER
Pituitary Tumors Treatment Topics
- Purpose of This PDQ Summary
- General Information
- Cellular Classification
- Stage Information
- Treatment Option Overview
- Prolactin-Producing Pituitary Tumors
- Adrenocorticotropic Hormone-Producing Pituitary Tumors
- Growth Hormone-Producing Pituitary Tumors
Important Safety Information
Vimpat (lacosamide) is a medicine that is used with other medicines to treat partial onset seizures in patients 17 years of age and older with epilepsy. Vimpat is generally well-tolerated, but may not be for everyone. Ask your doctor if Vimpat is right for you. Antiepileptic drugs, including Vimpat, may cause suicidal thoughts or actions in a very small number of people, about 1 in 500. Call your healthcare provider right away if you have new or worsening symptoms of depression, any unusual changes in mood or behavior, or suicidal thoughts, behavior, or thoughts about self harm that you have never had before or may be worse than before. Please see additional patient information in the Medication Guide at the end of the full prescribing information. This information does not take the place of talking with your healthcare provider about your condition or your treatment. Please see additional Patient Safety Information

